scispace - formally typeset
Open AccessJournal ArticleDOI

Diagnosis and management of the venous malformations of Klippel-Trénaunay syndrome.

Reads0
Chats0
TLDR
In this article, the etiology, diagnosis, and treatment of Klippel-Trenaunay syndrome (KTS) was reviewed and described, which is characterized by a clinical triad of extremity varicosities, cutaneous vascular malformations, and hypertrophy of soft tissues and long bones.
Abstract
Objective A dearth of information exists in the literature regarding current practice in the management of Klippel-Trenaunay syndrome (KTS), a rare condition. We review and describe the etiology, diagnosis, and treatment of KTS. Methods Relevant data were synthesized from a Medline review using a combination of the keyterms “Klippel” and “Trenaunay.” The majority of hits described singular case reports and were subsequently excluded. The remaining papers were then reviewed and included on the basis of the quality of evidence and the authors' discretion. Conclusions KTS is characterized by a clinical triad of extremity varicosities, cutaneous vascular malformations, and hypertrophy of soft tissues and long bones. The diagnosis is clinically supplemented with magnetic resonance imaging and computed tomography. Although this syndrome is associated with significant comorbidities, such as pain, edema, ulcerations, and pruritus, it is rarely the cause of death. The backbone of treatment is nonoperative in nature but should be supplemented with minimally invasive, endovascular, and rarely open surgical procedures for refractory cases.

read more

Content maybe subject to copyright    Report

1
Diagnosis and Management of the Venous Malformations of Klippel-Trenaunay
Syndrome
S. Keisin Wang MD
1,2
, Natalie A. Drucker MD
1
, Alok K. Gupta
1,2
, Francis E.
Marshalleck MD
3
, and Michael C. Dalsing MD
1,2
Indiana University School of Medicine,
1
Departments of Surgery,
2
Division of Vascular
Surgery, and
3
Department of Radiology
Corresponding Authors:
Michael C. Dalsing, MD
mdalsing@iupui.edu
1801 N. Senate St
Suite 3500
Indianapolis, IN 46202
S. Keisin Wang, MD
wangkei@iupui.edu
1801 N. Senate St
Suite 3500
Indianapolis, IN 46202
___________________________________________________________________
This is the author's manuscript of the article published in final edited form as:
Wang, S. K., Drucker, N. A., Gupta, A. K., Marshalleck, F. E., & Dalsing, M. C. (2017). Diagnosis and management of
the venous malformations of Klippel-Trénaunay syndrome. Journal of Vascular Surgery: Venous and Lymphatic
Disorders, 5(4), 587-595. https://doi.org/10.1016/j.jvsv.2016.10.084

2
Abstract:
Objective
A dearth of information exists in the literature regarding current practice in the
management of Klippel-Trenaunay Syndrome (KTS), a rare condition. We seek to
review and describe the etiology, diagnosis, and treatment of the KTS patient.
Methods
Relevant data was synthesized from a Medline review using a combination of key
terms “Klippel” and “Trenaunay”. Majority of hits described singular case reports and
were subsequently excluded. Remaining papers were then reviewed and included based
on quality of evidence and author discretion.
Conclusion
KTS is characterized by a clinical triad of extremity varicosities, cutaneous
vascular malformations, and hypertrophy of soft tissues and/or long bones. The diagnosis
is clinically supplemented with MRI and CT scanning. Although this syndrome is
associated with significant comorbidities such as pain, edema, ulcerations, and pruritus –
it is rarely the cause of mortality. The backbone of treatment is nonoperative in nature but
should be supplemented with minimally invasive, endovascular, and rarely open surgical
procedures for refractory cases.

3
Introduction:
Vascular malformations of Klippel-Trenaunay syndrome (KTS) usually affect the
capillary, venous, and lymphatic systems of the lower extremities. Rarely, these defects
are seen in the upper extremities, are bilateral, or involve the trunk. Although first
described by Hilaire in 1832, KTS was truly recognized as an entity in itself by its
namesakes at the turn of the 20
th
century.
(1)
The duo of Frenchmen defined a cohort of
patients presenting with a triad of asymmetric limb hypertrophy, localized capillary
malformation (nevus flammeus, “port-wine stain”), and congenital lower extremity
varicosities. Although KTS is generally benign in course, the diseased limb can exhibit
pain, swelling, hyperpigmentation, thrombophlebitis, variceal bleeding, and ulceration.
Shortly after description by Klippel and Trenaunay, Weber designated a similar
vascular syndrome with the addition of arteriovenous fistulas (AVFs) termed the Parkes-
Weber Syndrome (PWS).
(2)
This separate pathology has been the source of much
confusion since the mid-20
th
century as clinicians have often ascribed one as the other.
However, there are crucial differences which affect the clinical course. With addition of
high flow AVFs, those suffering from PWS have a decreased lifespan and more
significant arterial complications compared to the more benign KTS.
Much effort has been made to unify the criteria of KTS in order to clarify the
clinical condition, the first step in diagnosis and management. Currently, the best
classification of venous malformations, of which KTS is one, is the Hamburg

4
Classification of Congenital Vascular Malformations. Utilizing this tool, KTS would be
classified as a predominantly venous defect of the truncular anatomic form presenting
with aplasia, obstruction, and/or dilatation. Truncular forms arises after developmental
arrest and during vascular trunk formation; in other words, these lesions do not have the
ability to proliferate after removal.
(3, 4)
The true pathogenesis of KTS has been elusive. While most patients demonstrate
a normal karyotype, sporadic translocations have been reported of chromosomes 5-11 and
8-14; a supernumerary ringed chromosome 18 have also been described. Familial cases
are rarely (and often unreliably) reported.
(5)
The affected limbs tend to exhibit increased
blood flow; this has been thought related to VEGF-mediated angiogenesis, but no
definitive evidence has been brought forth. There also may be involvement of gain-of-
function PIK3CA gene mutations causing upregulation of AKT and mTOR signaling.
(6)
PI3K and mTOR inhibitors are currently being investigated as treatment options with
promising results in mice and humans.
(7-9)
At least 6 hypothetical causes of KTS have
been suggested in the literature; of which, none completely explains the entire clinical
spectrum.
(5)

5
Presentation:
KTS is clinically diagnosed by the observation of a triad of cutaneous capillary
malformations, varicosities, and hypertrophy soft tissues and/or long bones. However, a
spectrum and combination of the aforementioned is usually appreciated in the real world.
In addition, while this classical presentation is usually observed in a singular limb,
multiple and even whole body cases have been described.
(10)
Limb length discrepancy is most often secondary to underlying soft tissue growth
but can be associated with long bone hypertrophy. The difference in growth occurs
during childhood before stabilizing in young adulthood with minimal changes after the
teenage years.
(11)
Capillary malformations present on the hypertrophied limb and clinically appear
as flat hemangiomas. In contrast, true flow-limiting arterial pathology is exceedingly rare
in KTS and more characteristic of the more pathologic PWS. A cutaneous capillary
malformation is often the first and most obvious sign on examination of the patient
suspected of KTS. This is often referred to in the literature as a “port-wine stain”.
Frequently dermatomal in distribution, these lesions tend to bleed and persist as the
patient ages. The frequency of which these skin findings coexist in KTS cannot be
understated; in fact, the prevalence of capillary malformations approaches 100% in the
reported literature.
(12)

Citations
More filters
Journal ArticleDOI

Klippel and Trenaunayʼs syndrome: 768 operated cases

TL;DR: Knowledge of the pathophysiology of these malformations of the deep veins enables a better understanding of the clinical manifestations of the condition, as well as the improved treatment of the serious vesical or rectal hemorrhage which occurs in one per cent of these patients.
Journal ArticleDOI

Vascular malformations syndromes: an update.

TL;DR: A review of vascular malformation syndromes by reviewing the most recent articles on the topic and following the new International Society for the Study of Vascular Anomalies (ISSVA) 2018 classification is presented in this paper.
Journal ArticleDOI

The etiology of the Klippel-Trenaunay syndrome

TL;DR: The authors suggest that KTS is caused by mesodermal abnormality during fetal development, leading to the maintenance of microscopic arteriovenous communications in the limb bud, as a result of which the triad of nevus, hypertrophy, and superficial varices is produced.
Journal ArticleDOI

Imaging Findings of Klippel-Trenaunay Syndrome.

TL;DR: Findings include neurospinal as cavernoma, aneurysm, and hemimegalencephaly, pulmonary as pulmonary thromboembolism and pulmonary hypertension and visceral as gastrointestinal and genitourinary vascular anomalies.
Journal ArticleDOI

Evaluation and management of the lateral marginal vein in Klippel-Trénaunay and other PIK3CA-related overgrowth syndromes.

TL;DR: A systematic approach to diagnosis and treatment of this anomaly is warranted and expounded on herein, and clinical recommendations based on best available literature are made.
References
More filters
Journal ArticleDOI

Klippel-Trénaunay syndrome: spectrum and management.

TL;DR: Most patients with Klippel-Trénaunay syndrome should be managed conservatively, and the clearest indication for operation is a leg length discrepancy projected to exceed 2.0 cm at skeletal maturity, which can be treated with epiphysiodesis in the growing child.
Related Papers (5)
Frequently Asked Questions (8)
Q1. What are the contributions in "Diagnosis and management of the venous malformations of klippel-trenaunay syndrome" ?

The authors seek to review and describe the etiology, diagnosis, and treatment of the KTS patient. 

The backbone of treatment is nonoperative in nature but should be supplemented with minimally invasive, endovascular, and rarely open surgical procedures for refractory cases. 

Although KTS is generally benign in course, the diseased limb can exhibit pain, swelling, hyperpigmentation, thrombophlebitis, variceal bleeding, and ulceration. 

(1) The duo of Frenchmen defined a cohort of patients presenting with a triad of asymmetric limb hypertrophy, localized capillary malformation (nevus flammeus, “port-wine stain”), and congenital lower extremity varicosities. 

Truncular forms arises after developmental arrest and during vascular trunk formation; in other words, these lesions do not have the ability to proliferate after removal. 

the best classification of venous malformations, of which KTS is one, is the HamburgClassification of Congenital Vascular Malformations. 

While most patients demonstratea normal karyotype, sporadic translocations have been reported of chromosomes 5-11 and 8-14; a supernumerary ringed chromosome 18 have also been described. 

Introduction:Vascular malformations of Klippel-Trenaunay syndrome (KTS) usually affect thecapillary, venous, and lymphatic systems of the lower extremities.